Adenosine A3 Receptor, Rat (A3AR) (Control Peptide)
Catalog No : USB-A0869-70G
417.25€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | Adenosine A3 Receptor, Rat (A3AR) (Control Peptide) | ||
|---|---|---|---|
| Catalog No | USB-A0869-70G | ||
| Supplier’s Catalog No | A0869-70G | ||
| Supplier | US Biologicals | ||
| Source antigen | Rat synthetic peptide | ||
| Reactivity | |||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | |||
| Storage | -20°C | ||
|---|---|---|---|
| Other names | |||
| Grade | Highly Purified | ||
| Purity | Highly purified | ||
| Form | Supplied as a liquid in PBS, pH 7.4 | ||
| Reactivity life | 12 months | ||
| Note | For reserch purpose only | ||
| Purity | Highly purified | ||
| Description | A 15 amino acid sequence corresponding to rat A3R gene. This region corresponds to the 3rd extracellular domain. This sequence demonstrates 46% homology (7/15 AA) with human and 20% (3/15 AA) with sheep A3R sequences. Adenosine deaminase (ADA; EC 3.54.4) catalyzes deamination of adenosine to inosine. ADA is found in primarily cytosolic. It has also been located at the cell membrane and implicated in the control of the extracellular concentration of adenosine. The purine nucleoside adenosine modulates diverse physiological functions including induction of sedation, vasodilatation, suppression of cardiac rate and contractility, neurotransmitter release, inhibition of platelet aggregation and lipolysis. Adenosine released from cells interacts with membrane receptors (adenosine receptors, ARs). Based upon, biochemical and pharmacological criteria, ARs have been classified into A1, A2a, A2b, and A3. The high affinity receptor A1 inhibits adenyl cyclase, whereas low affinity receptor A2a stimulates the cyclase via G proteins. A2a receptor is believed to cause vasorelaxation in coronary artery. Various, ARs and their subtypes have recently been cloned from several species. ARs belong to the superfamily of G-protein coupled receptors and predicted to contain 7 transmembrane domains. The N-termini are predicted to be extracellular and the C-termini cytoplasmic. There is an overall 30% homology among the four ARs. ARs are distributed throughout the body. Gene location of various ARs: A1 (Chromosome 1; q.31.3-32.2); A2a (Chromosome 22); A2b (Chromosome 17; p.11.2-12); A3 (Chromos.1). Applications: Suitable for use in ELISA and Antibody Blocking. Not suitable for Western Blot. Other applications not tested. Recommended Dilution: ELISA: 50-100ng A3R control peptide per well. Antibody Blocking: 5-10ug control peptide per 1ug A0869-70K (affinity purified antibody) or 1ul A0869-70D (antiserum). Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4°C for short-term only. For long-term storage, store at -20°C. Aliquots are stable for at least 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. | ||
Product Details
© 2020 Imugex All Rights Reserved